A open-label study of entecavir for chronic hepatitis B to determine the optimum duration of administration
Latest Information Update: 01 Sep 2015
Price :
$35 *
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 30 Aug 2015 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan .
- 19 Jan 2014 New trial record